• Return to Headlines

Intra-Cellular T Has Returned 10.3% Since SmarTrend Recommendation (ITCI)

By James Quinn

SmarTrend identified an Uptrend for Intra-Cellular T (NASDAQ:ITCI) on October 29th, 2019 at $8.92. In approximately 1 month, Intra-Cellular T has returned 10.26% as of today's recent price of $9.84.

In the past 52 weeks, shares of Intra-Cellular T have traded between a low of $7.85 and a high of $44.92 and are now at $9.84, which is 25% above that low price. Over the past week, the 200-day moving average (MA) has gone down 0.5% while the 50-day MA has advanced 0.3%.

Intra-Cellular Therapies Inc. researches and develops biopharmaceutical drugs. The Company engages in the research and development of small molecule drugs to treat neuropsychiatric and neurological diseases and other disorders of the central nervous system. Intra-Cellular Therapies offers its products to the medical industry.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of Intra-Cellular T shares.

Log in and add Intra-Cellular T (ITCI) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights intra-cellular t

Ticker(s): ITCI